| EX0850 HEMOPHILIA A CARRIER DETECTION |
| Specimen: |
3 mL whole blood in 1 Blue Top (Sodium Citrate) tube. Mix thoroughly by inversion. Transport to Lab within 4 hours. If this is not possible, make PPP within 1 hour of the collection as follows: Centrifuge sample at 3600 rpm for 15 min. & transfer supernatant to a clean plastic tube. Centrifuge this supernatant again at 3600 rpm for 15 mins. & finally, transfer the supernatant (PPP) to 1 labeled clean plastic screw-capped vial. FREEZE IMMEDIATELY. Ship frozen. DO NOT THAW. Overnight fasting is preferred. |
| Stability: |
| Room |
Refrigerated |
Frozen |
| 4 hrs |
4 hrs |
2 weeks |
|
| Method: |
Electromechanical Clot Detection, EIA |
| Comment: |
It is recommended that the patient discontinues Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with the prior consent of the treating Physician. |
| Report: |
Contact us to know the TAT. |
| Usage: |
In females, the ratio of Factor VIII activity to the level of vWF antigen is used to predict carrier status. Ratios less than 1 identify 95-99% of Hemophilia A carriers. |
| Doctor Specialty: |
Hematologist |
| Disease: |
Disorders of Coagulation |
| Components: |
*Factor VIII *vWF Antigen *Factor VIII / vWF Ratio |
| Courier Charges: |
0.00 |
| Home Collection: |
Available (*T&C Apply) |
| Department: |
Coagulation |
| Pre Test Information: |
Overnight fasting is preferred. A duly filled Coagulation Requisition Form is mandatory. It is recommended that the patient discontinues Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with the prior consent of the treating Physician. |
Reviews
There are no reviews yet.